Preview
Sign-in for full Details 
Sign-in free and Explore the Exciting World of BiomedExperts:
- Over 1.500.000 Profiles
- More than 1.800 Organizations worldwide
- State of the Art Network Visualizations
- Manage your own Profile
- Locate Experts in your Country/Region
- Locate Experts in your 1. and 2. Level Network
- Connect to Experts Worldwide
NetworkView
David Rimm
This is a preview profile on BiomedExperts - the first literature-based scientific social network. It brings the right researchers
together and allows them to collaborate online. Collexis and Dell provide the BiomedExperts network of +1.5 Million pre-calculated profiles
free of charge to researchers worldwide.
Research Profile (preview)
Disorders
Chemicals & Drugs
Procedures
Concepts & Ideas
Devices
Anatomy
Sign-in to see full Profile
Network (preview)
59
Camp, Robert
20
Kluger, Harriet
12
Psyrri, Amanda
12
Berger, Aaron
12
Dolled-Filhart, Marisa
12
Haffty, Bruce
11
Weinberger, Paul
11
Yu, Ziwei
10
Harigopal, Malini
10
D'Aquila, Thomas
10
Chung, Gina
10
Kowalski, Diane
9
Giltnane, Jena
8
Morrow, Jon
7
Pollard, Thomas
Sign-in to see all Coauthors
Publications
Sign-in to see all Publications
Sign in free and see...
Visualized networks:
See your personal network in
sophisticated graphical views
GeoTargeted Searches:
Locate experts around the world
and connect with global collaborators
Research Profiles:
See the visualized research activity
of experts around the globe
Sign-in to see more
Geonetwork of David Rimm (preview)
Cities where this author has publications
Cities where co-authors of this author have publications
Sign-in to see more
All Publications
-
2009: Jilaveanu Lucia B; Zito Christopher R; Aziz Saadia A; Conrad Patricia J; Schmitz John C; Sznol Mario; Camp Robert L; Rimm David L; Kluger Harriet M
C-Raf is associated with disease progression and cell proliferation in a subset of melanomas.
Clinical cancer research : an official journal of the American Association for Cancer Research 2009;15(18):5704-13.
-
2009: Weinberger Paul M; Yu Ziwei; Kountourakis Panteleimon; Sasaki Clarence; Haffty Bruce G; Kowalski Diane; Merkley Mark A; Rimm David L; Camp Robert L; Psyrri Amanda
Defining molecular phenotypes of human papillomavirus-associated oropharyngeal squamous cell carcinoma: validation of three-class hypothesis.
Otolaryngology--head and neck surgery : official journal of American Academy of Otolaryngology-Head and Neck Surgery 2009;141(3):382-9.
-
2009: Anagnostou Valsamo K; Bepler Gerold; Syrigos Konstantinos N; Tanoue Lynn; Gettinger Scott; Homer Robert J; Boffa Daniel; Detterbeck Frank; Rimm David L
High expression of mammalian target of rapamycin is associated with better outcome for patients with early stage lung adenocarcinoma.
Clinical cancer research : an official journal of the American Association for Cancer Research 2009;15(12):4157-64.
-
2009: Giltnane Jennifer M; Moeder Christopher B; Camp Robert L; Rimm David L
Quantitative multiplexed analysis of ErbB family coexpression for primary breast cancer prognosis in a large retrospective cohort.
Cancer 2009;115(11):2400-9.
-
2009: Aziz Saadia A; Davies Michael; Pick Elah; Zito Christopher; Jilaveanu Lucia; Camp Robert L; Rimm David L; Kluger Yuval; Kluger Harriet M
Phosphatidylinositol-3-kinase as a therapeutic target in melanoma.
Clinical cancer research : an official journal of the American Association for Cancer Research 2009;15(9):3029-36.
-
2009: Harigopal Malini; Heymann Jonas; Ghosh Sriparna; Anagnostou Valsamo; Camp Robert L; Rimm David L
Estrogen receptor co-activator (AIB1) protein expression by automated quantitative analysis (AQUA) in a breast cancer tissue microarray and association with patient outcome.
Breast cancer research and treatment 2009;115(1):77-85.
-
2009: Gould Rothberg Bonnie E; Bracken Michael B; Rimm David L
Tissue biomarkers for prognosis in cutaneous melanoma: a systematic review and meta-analysis.
Journal of the National Cancer Institute 2009;101(7):452-74.
-
2009: Agarwal S; Zerillo C; Kolmakova J; Christensen J G; Harris L N; Rimm D L; Digiovanna M P; Stern D F
Association of constitutively activated hepatocyte growth factor receptor (Met) with resistance to a dual EGFR/Her2 inhibitor in non-small-cell lung cancer cells.
British journal of cancer 2009;100(6):941-9.
-
2009: Jilaveanu Lucia; Zito Christopher; Lee Sandra J; Nathanson Katherine L; Camp Robert L; Rimm David L; Flaherty Keith T; Kluger Harriet M
Expression of sorafenib targets in melanoma patients treated with carboplatin, paclitaxel and sorafenib.
Clinical cancer research : an official journal of the American Association for Cancer Research 2009;15(3):1076-85.
-
2009: Sullivan C A W; Ghosh S; Ocal I T; Camp R L; Rimm David L; Chung G G
Microvessel area using automated image analysis is reproducible and is associated with prognosis in breast cancer.
Human pathology 2009;40(2):156-65.
-
2009: Anagnostou Valsamo K; Syrigos Konstantinos N; Bepler Gerold; Homer Robert J; Rimm David L
Thyroid transcription factor 1 is an independent prognostic factor for patients with stage I lung adenocarcinoma.
Journal of clinical oncology : official journal of the American Society of Clinical Oncology 2009;27(2):271-8.
-
2009: Hanna Jason A; Bordeaux Jennifer; Rimm David L; Agarwal Seema
The function, proteolytic processing, and histopathology of Met in cancer.
Advances in cancer research 2009;103():1-23.
-
2009: Moeder Christopher B; Giltnane Jennifer M; Moulis Sharon Pozner; Rimm David L
Quantitative, fluorescence-based in-situ assessment of protein expression.
Methods in molecular biology (Clifton, N.J.) 2009;520():163-75.
-
2009: Emerson John W; Dolled-Filhart Marisa; Harris Lyndsay; Rimm David L; Tuck David P
Quantitative assessment of tissue biomarkers and construction of a model to predict outcome in breast cancer using multiple imputation.
Cancer informatics 2009;7():29-40.
-
2008: Camp Robert L; Neumeister Veronique; Rimm David L
A decade of tissue microarrays: progress in the discovery and validation of cancer biomarkers.
Journal of clinical oncology : official journal of the American Society of Clinical Oncology 2008;26(34):5630-7.
-
2008: Ghosh Sriparna; Sullivan Catherine A W; Zerkowski Maciej P; Molinaro Annette M; Rimm David L; Camp Robert L; Chung Gina G
High levels of vascular endothelial growth factor and its receptors (VEGFR-1, VEGFR-2, neuropilin-1) are associated with worse outcome in breast cancer.
Human pathology 2008;39(12):1835-43.
-
2008: Gustavson Mark D; Molinaro Annette M; Tedeschi Greg; Camp Robert L; Rimm David L
AQUA analysis of thymidylate synthase reveals localization to be a key prognostic biomarker in 2 large cohorts of colorectal carcinoma.
Archives of pathology & laboratory medicine 2008;132(11):1746-52.
-
2008: Giltnane Jennifer M; Molinaro Annette; Cheng Huan; Robinson Andrew; Turbin Dmitry; Gelmon Karen; Huntsman David; Rimm David L
Comparison of quantitative immunofluorescence with conventional methods for HER2/neu testing with respect to response to trastuzumab therapy in metastatic breast cancer.
Archives of pathology & laboratory medicine 2008;132(10):1635-47.
-
2008: Rothberg Bonnie E Gould; Moeder Christopher B; Kluger Harriet; Halaban Ruth; Elder David E; Murphy George F; Lazar Alexander; Prieto Victor; Duncan Lynn McDivitt; Rimm David L
Nuclear to non-nuclear Pmel17/gp100 expression (HMB45 staining) as a discriminator between benign and malignant melanocytic lesions.
Modern pathology : an official journal of the United States and Canadian Academy of Pathology, Inc 2008;21(9):1121-9.
-
2008: Nadler Yasmine; Camp Robert L; Schwartz Candice; Rimm David L; Kluger Harriet M; Kluger Yuval
Expression of Aurora A (but not Aurora B) is predictive of survival in breast cancer.
Clinical cancer research : an official journal of the American Association for Cancer Research 2008;14(14):4455-62.
-
2008: Kreizenbeck Gretchen M; Berger Aaron J; Subtil Antonio; Rimm David L; Gould Rothberg Bonnie E
Prognostic significance of cadherin-based adhesion molecules in cutaneous malignant melanoma.
Cancer epidemiology, biomarkers & prevention : a publication of the American Association for Cancer Research, cosponsored by the American Society of Preventive Oncology 2008;17(4):949-58.
-
2008: McCarthy M M; Pick E; Kluger Y; Gould-Rothberg B; Lazova R; Camp R L; Rimm D L; Kluger H M
HSP90 as a marker of progression in melanoma.
Annals of oncology : official journal of the European Society for Medical Oncology / ESMO 2008;19(3):590-4.
-
2008: Mansoor Ibrahim; Zalles Carola; Zahid Farhan; Gossage Kirk; Levenson Richard M; Rimm David L
Fine-needle aspiration of follicular adenoma versus parathyroid adenoma: the utility of multispectral imaging in differentiating lesions with subtle cytomorphologic differences.
Cancer 2008;114(1):22-6.
-
2008: Nadler Yasmine; Camp Robert L; Giltnane Jennifer M; Moeder Christopher; Rimm David L; Kluger Harriet M; Kluger Yuval
Expression patterns and prognostic value of Bag-1 and Bcl-2 in breast cancer.
Breast cancer research : BCR 2008;10(2):R35.
-
2007: Moeder Christopher B; Giltnane Jennifer M; Harigopal Malini; Molinaro Annette; Robinson Andrew; Gelmon Karen; Huntsman David; Camp Robert L; Rimm David L;
Quantitative justification of the change from 10% to 30% for human epidermal growth factor receptor 2 scoring in the American Society of Clinical Oncology/College of American Pathologists guidelines: tumor heterogeneity in breast cancer and its implications for tissue microarray based assessment of outcome.
Journal of clinical oncology : official journal of the American Society of Clinical Oncology 2007;25(34):5418-25.
-
2007: Yang Xiaohong R; Pfeiffer Ruth M; Garcia-Closas Montserrat; Rimm David L; Lissowska Jolanta; Brinton Louise A; Peplonska Beata; Hewitt Stephen M; Cartun Richard W; Mandich Daniza; Sasano Hironobu; Evans Dean B; Sutter Thomas R; Sherman Mark E
Hormonal markers in breast cancer: coexpression, relationship with pathologic characteristics, and risk factor associations in a population-based study.
Cancer research 2007;67(21):10608-17.
-
2007: Handerson Tamara; Berger Aaron; Harigopol Malini; Rimm David; Nishigori Chikako; Ueda Masato; Miyoshi Eiji; Taniguchi Naoyuki; Pawelek John
Melanophages reside in hypermelanotic, aberrantly glycosylated tumor areas and predict improved outcome in primary cutaneous malignant melanoma.
Journal of cutaneous pathology 2007;34(9):679-86.
-
2007: Sherman Mark E; Rimm David L; Yang Xiaohong R; Chatterjee Nilanjan; Brinton Louise A; Lissowska Jolanta; Peplonska Beata; Szeszenia-Dabrowska Neonila; Zatonski Witold; Cartun Richard; Mandich Daniza; Rymkiewicz Grzegorz; Ligaj Marcin; Lukaszek Stanislaw; Kordek Radzislaw; Kalaylioglu Zynep; Harigopal Malini; Charrette Lori; Falk Roni T; Richesson Douglas; Anderson William F; Hewitt Stephen M; García-Closas Montserrat
Variation in breast cancer hormone receptor and HER2 levels by etiologic factors: a population-based analysis.
International journal of cancer. Journal international du cancer 2007;121(5):1079-85.
-
2007: Giltnane Jennifer M; Rydén Lisa; Cregger Melissa; Bendahl Pär-Ola; Jirström Karin; Rimm David L
Quantitative measurement of epidermal growth factor receptor is a negative predictive factor for tamoxifen response in hormone receptor positive premenopausal breast cancer.
Journal of clinical oncology : official journal of the American Society of Clinical Oncology 2007;25(21):3007-14.
-
2007: Chung Gina G; Zerkowski Maciej P; Ghosh Sriparna; Camp Robert L; Rimm David L
Quantitative analysis of estrogen receptor heterogeneity in breast cancer.
Laboratory investigation; a journal of technical methods and pathology 2007;87(7):662-9.
-
2007: Rimm David L; Giltnane Jennifer M; Moeder Christopher; Harigopal Malini; Chung Gina G; Camp Robert L; Burtness Barbara
Bimodal population or pathologist artifact?
Journal of clinical oncology : official journal of the American Society of Clinical Oncology 2007;25(17):2487-8.
-
2007: Pick Elah; Kluger Yuval; Giltnane Jennifer M; Moeder Christopher; Camp Robert L; Rimm David L; Kluger Harriet M
High HSP90 expression is associated with decreased survival in breast cancer.
Cancer research 2007;67(7):2932-7.
-
2007: Reshetnikova Galina; Troyanovsky Sergei; Rimm David L
Definition of a direct extracellular interaction between Met and E-cadherin.
Cell biology international 2007;31(4):366-73.
-
2007: Yu Ziwei; Weinberger Paul M; Sasaki Clarence; Egleston Brian L; Speier William F; Haffty Bruce; Kowalski Diane; Camp Robert; Rimm David; Vairaktaris Eleftherios; Burtness Barbara; Psyrri Amanda
Phosphorylation of Akt (Ser473) predicts poor clinical outcome in oropharyngeal squamous cell cancer.
Cancer epidemiology, biomarkers & prevention : a publication of the American Association for Cancer Research, cosponsored by the American Society of Preventive Oncology 2007;16(3):553-8.
-
2007: Yang Xiaohong R; Sherman Mark E; Rimm David L; Lissowska Jolanta; Brinton Louise A; Peplonska Beata; Hewitt Stephen M; Anderson William F; Szeszenia-Dabrowska Neonila; Bardin-Mikolajczak Alicja; Zatonski Witold; Cartun Richard; Mandich Daniza; Rymkiewicz Grzegorz; Ligaj Marcin; Lukaszek Stanislaw; Kordek Radzisaw; García-Closas Montserrat
Differences in risk factors for breast cancer molecular subtypes in a population-based study.
Cancer epidemiology, biomarkers & prevention : a publication of the American Association for Cancer Research, cosponsored by the American Society of Preventive Oncology 2007;16(3):439-43.
-
2007: Pozner-Moulis Sharon; Cregger Melissa; Camp Robert L; Rimm David L
Antibody validation by quantitative analysis of protein expression using expression of Met in breast cancer as a model.
Laboratory investigation; a journal of technical methods and pathology 2007;87(3):251-60.
-
2007: Zerkowski Maciej P; Camp Robert L; Burtness Barbara A; Rimm David L; Chung Gina G
Quantitative analysis of breast cancer tissue microarrays shows high cox-2 expression is associated with poor outcome.
Cancer investigation 2007;25(1):19-26.
-
2007: Shields Janiel M; Thomas Nancy E; Cregger Melissa; Berger Aaron J; Leslie Michael; Torrice Chad; Hao Honglin; Penland Shannon; Arbiser Jack; Scott Glynis; Zhou Tong; Bar-Eli Menashe; Bear James E; Der Channing J; Kaufmann William K; Rimm David L; Sharpless Norman E
Lack of extracellular signal-regulated kinase mitogen-activated protein kinase signaling shows a new type of melanoma.
Cancer research 2007;67(4):1502-12.
-
2007: Kluger Harriet M; McCarthy Mary M; Alvero Ayesha B; Sznol Mario; Ariyan Stephan; Camp Robert L; Rimm David L; Mor Gil
The X-linked inhibitor of apoptosis protein (XIAP) is up-regulated in metastatic melanoma, and XIAP cleavage by Phenoxodiol is associated with Carboplatin sensitization.
Journal of translational medicine 2007;5():6.
-
2006: Bamias A; Yu Z; Weinberger P M; Markakis S; Kowalski D; Camp R L; Rimm D L; Dimopoulos M A; Psyrri A
Automated quantitative analysis of DCC tumor suppressor protein in ovarian cancer tissue microarray shows association with beta-catenin levels and outcome in patients with epithelial ovarian cancer.
Annals of oncology : official journal of the European Society for Medical Oncology / ESMO 2006;17(12):1797-802.
-
2006: Dolled-Filhart Marisa; Rydén Lisa; Cregger Melissa; Jirström Karin; Harigopal Malini; Camp Robert L; Rimm David L
Classification of breast cancer using genetic algorithms and tissue microarrays.
Clinical cancer research : an official journal of the American Association for Cancer Research 2006;12(21):6459-68.
-
2006: Yang Xiaohong Rose; Charette Lori A; Garcia-Closas Montserrat; Lissowska Jolanta; Paal Edina; Sidawy Mary; Hewitt Stephen M; Rimm David L; Sherman Mark E
Construction and validation of tissue microarrays of ductal carcinoma in situ and terminal duct lobular units associated with invasive breast carcinoma.
Diagnostic molecular pathology : the American journal of surgical pathology, part B 2006;15(3):157-61.
-
2006: Pozner-Moulis Sharon; Pappas Derek J; Rimm David L
Met, the hepatocyte growth factor receptor, localizes to the nucleus in cells at low density.
Cancer research 2006;66(16):7976-82.
-
2006: Rimm David L
What brown cannot do for you.
Nature biotechnology 2006;24(8):914-6.
-
2006: Giltnane J M; Murren J R; Rimm D L; King B L
AQUA and FISH analysis of HER-2/neu expression and amplification in a small cell lung carcinoma tissue microarray.
Histopathology 2006;49(2):161-9.
-
2006: Cregger Melissa; Berger Aaron J; Rimm David L
Immunohistochemistry and quantitative analysis of protein expression.
Archives of pathology & laboratory medicine 2006;130(7):1026-30.
-
2006: McCarthy Mary M; DiVito Kyle A; Sznol Mario; Kovacs Daniela; Halaban Ruth; Berger Aaron J; Flaherty Keith T; Camp Robert L; Lazova Rossitza; Rimm David L; Kluger Harriet M
Expression of tumor necrosis factor--related apoptosis-inducing ligand receptors 1 and 2 in melanoma.
Clinical cancer research : an official journal of the American Association for Cancer Research 2006;12(12):3856-63.
-
2006: Psyrri Amanda; Yu Ziwei; Bamias Aris; Weinberger Paul M; Markakis Sonia; Kowalski Diane; Camp Robert L; Rimm David L; Dimopoulos Meletios A
Evaluation of the prognostic value of cellular inhibitor of apoptosis protein in epithelial ovarian cancer using automated quantitative protein analysis.
Cancer epidemiology, biomarkers & prevention : a publication of the American Association for Cancer Research, cosponsored by the American Society of Preventive Oncology 2006;15(6):1179-83.
-
2006: Cowan James D; Rimm David L; Tuck David P
Cruella: developing a scalable tissue microarray data management system.
Archives of pathology & laboratory medicine 2006;130(6):817-22.
-
2006: Pappas Derek J; Rimm David L
Direct interaction of the C-terminal domain of alpha-catenin and F-actin is necessary for stabilized cell-cell adhesion.
Cell communication & adhesion 2006;13(3):151-70.
-
2006: Dolled-Filhart Marisa; McCabe Anthony; Giltnane Jennifer; Cregger Melissa; Camp Robert L; Rimm David L
Quantitative in situ analysis of beta-catenin expression in breast cancer shows decreased expression is associated with poor outcome.
Cancer research 2006;66(10):5487-94.
-
2006: Chung Gina G; Yoon Harry H; Zerkowski Maciej P; Ghosh Sriparna; Thomas Laurie; Harigopal Malini; Charette Lori A; Salem Ronald R; Camp Robert L; Rimm David L; Burtness Barbara A
Vascular endothelial growth factor, FLT-1, and FLK-1 analysis in a pancreatic cancer tissue microarray.
Cancer 2006;106(8):1677-84.
-
2006: Ghofrani Mohiedean; Beckman Danita; Rimm David L
The value of onsite adequacy assessment of thyroid fine-needle aspirations is a function of operator experience.
Cancer 2006;108(2):110-3.
-
2006: Weinberger Paul M; Yu Ziwei; Haffty Bruce G; Kowalski Diane; Harigopal Malini; Brandsma Janet; Sasaki Clarence; Joe John; Camp Robert L; Rimm David L; Psyrri Amanda
Molecular classification identifies a subset of human papillomavirus--associated oropharyngeal cancers with favorable prognosis.
Journal of clinical oncology : official journal of the American Society of Clinical Oncology 2006;24(5):736-47.
-
2006: VanHouten Joshua N; Yu Namyi; Rimm David; Dotto Jorge; Arnold Andrew; Wysolmerski John J; Udelsman Robert
Hypercalcemia of malignancy due to ectopic transactivation of the parathyroid hormone gene.
The Journal of clinical endocrinology and metabolism 2006;91(2):580-3.
-
2005: McCabe Anthony; Dolled-Filhart Marisa; Camp Robert L; Rimm David L
Automated quantitative analysis (AQUA) of in situ protein expression, antibody concentration, and prognosis.
Journal of the National Cancer Institute 2005;97(24):1808-15.
-
2005: Psyrri Amanda; Kassar Mohamad; Yu Ziwei; Bamias Aris; Weinberger Paul M; Markakis Sonia; Kowalski Diane; Camp Robert L; Rimm David L; Dimopoulos Meletios A
Effect of epidermal growth factor receptor expression level on survival in patients with epithelial ovarian cancer.
Clinical cancer research : an official journal of the American Association for Cancer Research 2005;11(24 Pt 1):8637-43.
-
2005: Psyrri Amanda; Bamias Aris; Yu Ziwei; Weinberger Paul M; Kassar Mohamad; Markakis Sophia; Kowalski Diane; Efstathiou Eleni; Camp Robert L; Rimm David L; Dimopoulos Meletios A
Subcellular localization and protein levels of cyclin-dependent kinase inhibitor p27 independently predict for survival in epithelial ovarian cancer.
Clinical cancer research : an official journal of the American Association for Cancer Research 2005;11(23):8384-90.
-
2005: Berger Aaron J; Davis Darren W; Tellez Carmen; Prieto Victor G; Gershenwald Jeffrey E; Johnson Marcella M; Rimm David L; Bar-Eli Menashe
Automated quantitative analysis of activator protein-2alpha subcellular expression in melanoma tissue microarrays correlates with survival prediction.
Cancer research 2005;65(23):11185-92.
-
2005: Angeletti Cesar; Harvey Neal R; Khomitch Vitali; Fischer Andrew H; Levenson Richard M; Rimm David L
Detection of malignancy in cytology specimens using spectral-spatial analysis.
Laboratory investigation; a journal of technical methods and pathology 2005;85(12):1555-64.
-
2005: Siddiqui Summar F; Pawelek John; Handerson Tamara; Lin Chen-Yong; Dickson Robert B; Rimm David L; Camp Robert L
Coexpression of beta1,6-N-acetylglucosaminyltransferase V glycoprotein substrates defines aggressive breast cancers with poor outcome.
Cancer epidemiology, biomarkers & prevention : a publication of the American Association for Cancer Research, cosponsored by the American Society of Preventive Oncology 2005;14(11 Pt 1):2517-23.
-
2005: Choi Doo Ho; Kim Sung; Rimm David L; Carter Darryl; Haffty Bruce G
Immunohistochemical biomarkers in patients with early-onset breast carcinoma by tissue microarray.
Cancer journal (Sudbury, Mass.) 2005;11(5):404-11.
-
2005: Bast Robert C; Lilja Hans; Urban Nicole; Rimm David L; Fritsche Herbert; Gray Joe; Veltri Robert; Klee George; Allen Andrew; Kim Nam; Gutman Steven; Rubin Mark A; Hruszkewycz Andrew
Translational crossroads for biomarkers.
Clinical cancer research : an official journal of the American Association for Cancer Research 2005;11(17):6103-8.
-
2005: Psyrri Amanda; Yu Ziwei; Weinberger Paul M; Sasaki Clarence; Haffty Bruce; Camp Robert; Rimm David; Burtness Barbara Ann
Quantitative determination of nuclear and cytoplasmic epidermal growth factor receptor expression in oropharyngeal squamous cell cancer by using automated quantitative analysis.
Clinical cancer research : an official journal of the American Association for Cancer Research 2005;11(16):5856-62.
-
2005: McCarthy Mary M; Sznol Mario; DiVito Kyle A; Camp Robert L; Rimm David L; Kluger Harriet M
Evaluating the expression and prognostic value of TRAIL-R1 and TRAIL-R2 in breast cancer.
Clinical cancer research : an official journal of the American Association for Cancer Research 2005;11(14):5188-94.
-
2005: Kluger Harriet M; Chelouche Lev Dina; Kluger Yuval; McCarthy Mary M; Kiriakova Galina; Camp Robert L; Rimm David L; Price Janet E
Using a xenograft model of human breast cancer metastasis to find genes associated with clinically aggressive disease.
Cancer research 2005;65(13):5578-87.
-
2005: Harigopal Malini; Berger Aaron J; Camp Robert L; Rimm David L; Kluger Harriet M
Automated quantitative analysis of E-cadherin expression in lymph node metastases is predictive of survival in invasive ductal breast cancer.
Clinical cancer research : an official journal of the American Association for Cancer Research 2005;11(11):4083-9.
-
2005: Fadare Oluwole; Mariappan M Rajan; Hileeto Denise; Wang Sa; McAlpine Jessica N; Rimm David L
Upstaging based solely on positive peritoneal washing does not affect outcome in endometrial cancer.
Modern pathology : an official journal of the United States and Canadian Academy of Pathology, Inc 2005;18(5):673-80.
-
2005: Handerson Tamara; Camp Robert; Harigopal Malini; Rimm David; Pawelek John
Beta1,6-branched oligosaccharides are increased in lymph node metastases and predict poor outcome in breast carcinoma.
Clinical cancer research : an official journal of the American Association for Cancer Research 2005;11(8):2969-73.
-
2005: Provost Elayne; McCabe Anthony; Stern Jessica; Lizardi Isabel; D'Aquila Thomas G; Rimm David L
Functional correlates of mutation of the Asp32 and Gly34 residues of beta-catenin.
Oncogene 2005;24(16):2667-76.
-
2005: Yu Ziwei; Weinberger Paul M; Provost Elayne; Haffty Bruce G; Sasaki Clarence; Joe J; Camp R L; Rimm D L; Psyrri Amanda
beta-Catenin functions mainly as an adhesion molecule in patients with squamous cell cancer of the head and neck.
Clinical cancer research : an official journal of the American Association for Cancer Research 2005;11(7):2471-7.
-
2005: Yu Ziwei; Weinberger Paul M; Haffty Bruce G; Sasaki Clarence; Zerillo Cynthia; Joe John; Kowalski Diane; Dziura James; Camp Robert L; Rimm David L; Psyrri Amanda
Cyclin d1 is a valuable prognostic marker in oropharyngeal squamous cell carcinoma.
Clinical cancer research : an official journal of the American Association for Cancer Research 2005;11(3):1160-6.
-
2005: Higgins Susan A; Matloff Ellen T; Rimm David L; Dziura James; Haffty Bruce G; King Bonnie L
Patterns of reduced nipple aspirate fluid production and ductal lavage cellularity in women at high risk for breast cancer.
Breast cancer research : BCR 2005;7(6):R1017-22.
-
2004: Giltnane Jena M; Rimm David L
Technology insight: Identification of biomarkers with tissue microarray technology.
Nature clinical practice. Oncology 2004;1(2):104-11.
-
2004: Divito Kyle A; Berger Aaron J; Camp Robert L; Dolled-Filhart Marisa; Rimm David L; Kluger Harriet M
Automated quantitative analysis of tissue microarrays reveals an association between high Bcl-2 expression and improved outcome in melanoma.
Cancer research 2004;64(23):8773-7.
-
2004: Berger Aaron J; Camp Robert L; Divito Kyle A; Kluger Harriet M; Halaban Ruth; Rimm David L
Automated quantitative analysis of HDM2 expression in malignant melanoma shows association with early-stage disease and improved outcome.
Cancer research 2004;64(23):8767-72.
-
2004: Camp Robert L; Dolled-Filhart Marisa; Rimm David L
X-tile: a new bio-informatics tool for biomarker assessment and outcome-based cut-point optimization.
Clinical cancer research : an official journal of the American Association for Cancer Research 2004;10(21):7252-9.
-
2004: Weinberger Paul M; Yu Z; Haffty B G; Kowalski D; Harigopal M; Sasaki C; Rimm D L; Psyrri A
Prognostic significance of p16 protein levels in oropharyngeal squamous cell cancer.
Clinical cancer research : an official journal of the American Association for Cancer Research 2004;10(17):5684-91.
-
2004: Hoek Keith; Rimm David L; Williams Kenneth R; Zhao Hongyu; Ariyan Stephan; Lin Aiping; Kluger Harriet M; Berger Aaron J; Cheng Elaine; Trombetta E Sergio; Wu Terence; Niinobe Michio; Yoshikawa Kazuaki; Hannigan Gregory E; Halaban Ruth
Expression profiling reveals novel pathways in the transformation of melanocytes to melanomas.
Cancer research 2004;64(15):5270-82.
-
2004: DiVito Kyle A; Charette Lori A; Rimm David L; Camp Robert L
Long-term preservation of antigenicity on tissue microarrays.
Laboratory investigation; a journal of technical methods and pathology 2004;84(8):1071-8.
-
2004: Angeletti Cesar; Khomitch Vitali; Halaban Ruth; Rimm David L
Novel tyramide-based tyrosinase assay for the detection of melanoma cells in cytological preparations.
Diagnostic cytopathology 2004;31(1):33-7.
-
2004: Jaganath Rajesh; Angeletti Cesar; Levenson Richard; Rimm David L
Diagnostic classification of urothelial cells in urine cytology specimens using exclusively spectral information.
Cancer 2004;102(3):186-91.
-
2004: Fadare Oluwole; Mariappan M Rajan; Wang Sa; Hileeto Denise; McAlpine Jessica; Rimm David L
The histologic subtype of ovarian tumors affects the detection rate by pelvic washings.
Cancer 2004;102(3):150-6.
-
2004: Chelouche-Lev Dina; Kluger Harriet M; Berger Aaron J; Rimm David L; Price Janet E
alphaB-crystallin as a marker of lymph node involvement in breast carcinoma.
Cancer 2004;100(12):2543-8.
-
2004: Kluger Harriet M; DiVito Kyle; Berger Aaron J; Halaban Ruth; Ariyan Stephan; Camp Robert L; Rimm David L
Her2/neu is not a commonly expressed therapeutic target in melanoma -- a large cohort tissue microarray study.
Melanoma research 2004;14(3):207-10.
-
2004: Chung Gina G; Zerkowski Maciej P; Ocal Idris Tolgay; Dolled-Filhart Marisa; Kang Jung Y; Psyrri Amanda; Camp Robert L; Rimm David L
beta-Catenin and p53 analyses of a breast carcinoma tissue microarray.
Cancer 2004;100(10):2084-92.
-
2004: Rubin Mark A; Zerkowski Maciej P; Camp Robert L; Kuefer Rainer; Hofer Matthias D; Chinnaiyan Arul M; Rimm David L
Quantitative determination of expression of the prostate cancer protein alpha-methylacyl-CoA racemase using automated quantitative analysis (AQUA): a novel paradigm for automated and continuous biomarker measurements.
The American journal of pathology 2004;164(3):831-40.
-
2004: Kluger Harriet M; Dolled-Filhart Marisa; Rodov Sofya; Kacinski Barry M; Camp Robert L; Rimm David L
Macrophage colony-stimulating factor-1 receptor expression is associated with poor outcome in breast cancer by large cohort tissue microarray analysis.
Clinical cancer research : an official journal of the American Association for Cancer Research 2004;10(1 Pt 1):173-7.
-
2004: Haffty Bruce G; Hauser Analene; Choi Doo Ho; Parisot Nicole; Rimm David; King Bonnie; Carter Darryl
Molecular markers for prognosis after isolated postmastectomy chest wall recurrence.
Cancer 2004;100(2):252-63.
-
2003: Berger Aaron J; Kluger Harriet M; Li Ning; Kielhorn Eric; Halaban Ruth; Ronai Ze'ev; Rimm David L
Subcellular localization of activating transcription factor 2 in melanoma specimens predicts patient survival.
Cancer research 2003;63(23):8103-7.
-
2003: Provost Elayne; Yamamoto Yumi; Lizardi Isabel; Stern Jessica; D'Aquila Thomas G; Gaynor Richard B; Rimm David L
Functional correlates of mutations in beta-catenin exon 3 phosphorylation sites.
The Journal of biological chemistry 2003;278(34):31781-9.
-
2003: Kim Sung; Rimm David; Carter Darryl; Khan Atif; Parisot Nicole; Franco Mayra Alvarez; Bale Allen; Haffty Bruce G
BRCA status, molecular markers, and clinical variables in early, conservatively managed breast cancer.
The breast journal 2003;9(3):167-74.
-
2003: King Bonnie L; Tsai Steven C; Gryga Michele E; D'Aquila Thomas G; Seelig Steven A; Morrison Larry E; Jacobson Kris K B; Legator Mona S; Ward David C; Rimm David L; Phillips Rogsbert F
Detection of chromosomal instability in paired breast surgery and ductal lavage specimens by interphase fluorescence in situ hybridization.
Clinical cancer research : an official journal of the American Association for Cancer Research 2003;9(4):1509-16.
-
2003: Tolgay Ocal Idris; Dolled-Filhart Marisa; D'Aquila Thomas G; Camp Robert L; Rimm David L
Tissue microarray-based studies of patients with lymph node negative breast carcinoma show that met expression is associated with worse outcome but is not correlated with epidermal growth factor family receptors.
Cancer 2003;97(8):1841-8.
-
2003: Camp Robert L; Dolled-Filhart Marisa; King Bonnie L; Rimm David L
Quantitative analysis of breast cancer tissue microarrays shows that both high and normal levels of HER2 expression are associated with poor outcome.
Cancer research 2003;63(7):1445-8.
-
2003: Kang Jung Y; Dolled-Filhart Marisa; Ocal Idris Tolgay; Singh Baljit; Lin Chen-Yong; Dickson Robert B; Rimm David L; Camp Robert L
Tissue microarray analysis of hepatocyte growth factor/Met pathway components reveals a role for Met, matriptase, and hepatocyte growth factor activator inhibitor 1 in the progression of node-negative breast cancer.
Cancer research 2003;63(5):1101-5.
-
2003: Dolled-Filhart Marisa; Camp Robert L; Kowalski Diane P; Smith Bradley L; Rimm David L
Tissue microarray analysis of signal transducers and activators of transcription 3 (Stat3) and phospho-Stat3 (Tyr705) in node-negative breast cancer shows nuclear localization is associated with a better prognosis.
Clinical cancer research : an official journal of the American Association for Cancer Research 2003;9(2):594-600.
-
2003: Kielhorn Eric; Provost Elayne; Olsen Drew; D'Aquila Thomas G; Smith Bradley L; Camp Robert L; Rimm David L
Tissue microarray-based analysis shows phospho-beta-catenin expression in malignant melanoma is associated with poor outcome.
International journal of cancer. Journal international du cancer 2003;103(5):652-6.
-
2002: Camp Robert L; Chung Gina G; Rimm David L
Automated subcellular localization and quantification of protein expression in tissue microarrays.
Nature medicine 2002;8(11):1323-7.
-
2002: Ernst Linda M; Rimm David L
Quantitative examination of mechanophysical tumor cell enrichment in fine-needle aspiration specimens.
Cancer 2002;96(5):275-9.
-
2002: Dillon Deborah A; Hipolito Emanuel; Zheng Karl; Rimm David L; Costa José C
p53 mutations as tumor markers in fine needle aspirates of palpable breast masses.
Acta cytologica 2002;46(5):841-7.
-
2002: King Bonnie L; Crisi Giovanna M; Tsai Steven C; Haffty Bruce G; Phillips Rogsbert F; Rimm David L
Immunocytochemical analysis of breast cells obtained by ductal lavage.
Cancer 2002;96(4):244-9.
-
2002: Chung Gina G; Kielhorn Eric P; Rimm David L
Subjective differences in outcome are seen as a function of the immunohistochemical method used on a colorectal cancer tissue microarray.
Clinical colorectal cancer 2002;1(4):237-42.
-
2002: Kielhorn Eric; Schofield Kevin; Rimm David L
Use of magnetic enrichment for detection of carcinoma cells in fluid specimens.
Cancer 2002;94(1):205-11.
-
2001: Chung G G; Provost E; Kielhorn E P; Charette L A; Smith B L; Rimm D L
Tissue microarray analysis of beta-catenin in colorectal cancer shows nuclear phospho-beta-catenin is associated with a better prognosis.
Clinical cancer research : an official journal of the American Association for Cancer Research 2001;7(12):4013-20.
-
2001: Chen T; Yan W; Wells R G; Rimm D L; McNiff J; Leffell D; Reiss M
Novel inactivating mutations of transforming growth factor-beta type I receptor gene in head-and-neck cancer metastases.
International journal of cancer. Journal international du cancer 2001;93(5):653-61.
-
2001: Rimm D L; Camp R L; Charette L A; Olsen D A; Provost E
Amplification of tissue by construction of tissue microarrays.
Experimental and molecular pathology 2001;70(3):255-64.
-
2001: Garcia-Rostan G; Camp R L; Herrero A; Carcangiu M L; Rimm D L; Tallini G
Beta-catenin dysregulation in thyroid neoplasms: down-regulation, aberrant nuclear expression, and CTNNB1 exon 3 mutations are markers for aggressive tumor phenotypes and poor prognosis.
The American journal of pathology 2001;158(3):987-96.
-
2001: Reyes-Múgica M; Meyerhardt J A; Rzasa J; Rimm D L; Johnson K R; Wheelock M J; Reale M A
Truncated DCC reduces N-cadherin/catenin expression and calcium-dependent cell adhesion in neuroblastoma cells.
Laboratory investigation; a journal of technical methods and pathology 2001;81(2):201-10.
-
2001: Flynn K; Rimm D L
Diagnosis of "ASCUS" in women over age 50 is less likely to be associated with dysplasia.
Diagnostic cytopathology 2001;24(2):132-6.
-
2001: Pradhan D; Lombardo C R; Roe S; Rimm D L; Morrow J S
alpha -Catenin binds directly to spectrin and facilitates spectrin-membrane assembly in vivo.
The Journal of biological chemistry 2001;276(6):4175-81.
-
2001: Rimm D L; Camp R L; Charette L A; Costa J; Olsen D A; Reiss M
Tissue microarray: a new technology for amplification of tissue resources.
Cancer journal (Sudbury, Mass.) 2001;7(1):24-31.
-
2000: Camp R L; Charette L A; Rimm D L
Validation of tissue microarray technology in breast carcinoma.
Laboratory investigation; a journal of technical methods and pathology 2000;80(12):1943-9.
-
2000: Dillon D A; Johnson C C; Topazian M D; Tallini G; Rimm D L; Costa J C
The utility of Ki-ras mutation analysis in the cytologic diagnosis of pancreatobiliary neoplasma.
Cancer journal (Sudbury, Mass.) 2000;6(5):294-301.
-
2000: Schofield K; D'Aquila T; Rimm D L
E-cadherin expression is a sensitive and specific method for detection of carcinoma cells in fluid specimens.
Diagnostic cytopathology 2000;22(5):263-7.
-
2000: Rimm D L
Molecular biology in cytopathology: current applications and future directions.
Cancer 2000;90(1):1-9.
-
2000: Camp R L; Rimm E B; Rimm D L
A high number of tumor free axillary lymph nodes from patients with lymph node negative breast carcinoma is associated with poor outcome.
Cancer 2000;88(1):108-13.
-
1999: Camp R L; Rimm E B; Rimm D L
Met expression is associated with poor outcome in patients with axillary lymph node negative breast carcinoma.
Cancer 1999;86(11):2259-65.
-
1999: Provost E; Rimm D L
Controversies at the cytoplasmic face of the cadherin-based adhesion complex.
Current opinion in cell biology 1999;11(5):567-72.
-
1999: Garcia-Rostan G; Tallini G; Herrero A; D'Aquila T G; Carcangiu M L; Rimm D L
Frequent mutation and nuclear localization of beta-catenin in anaplastic thyroid carcinoma.
Cancer research 1999;59(8):1811-5.
-
1999: Rimm D L; Caca K; Hu G; Harrison F B; Fearon E R
Frequent nuclear/cytoplasmic localization of beta-catenin without exon 3 mutations in malignant melanoma.
The American journal of pathology 1999;154(2):325-9.
-
1998: Gold J S; Reynolds A B; Rimm D L
Loss of p120ctn in human colorectal cancer predicts metastasis and poor survival.
Cancer letters 1998;132(1-2):193-201.
-
1998: Magda J L; Minger B A; Rimm D L
Polymerase chain reaction-based detection of clonality as a non-morphologic diagnostic tool for fine-needle aspiration of the breast.
Cancer 1998;84(4):262-7.
-
1998: Roe S; Koslov E R; Rimm D L
A mutation in alpha-catenin disrupts adhesion in clone A cells without perturbing its actin and beta-catenin binding activity.
Cell adhesion and communication 1998;5(4):283-96.
-
1998: Ghoussoub R A; Dillon D A; D'Aquila T; Rimm E B; Fearon E R; Rimm D L
Expression of c-met is a strong independent prognostic factor in breast carcinoma.
Cancer 1998;82(8):1513-20.
-
1998: Dillon D A; D'Aquila T; Reynolds A B; Fearon E R; Rimm D L
The expression of p120ctn protein in breast cancer is independent of alpha- and beta-catenin and E-cadherin.
The American journal of pathology 1998;152(1):75-82.
-
1997: Gold J S; Bao L; Ghoussoub R A; Zetter B R; Rimm D L
Localization and quantitation of expression of the cell motility-related protein thymosin beta15 in human breast tissue.
Modern pathology : an official journal of the United States and Canadian Academy of Pathology, Inc 1997;10(11):1106-12.
-
1997: Schofield K; D'Aquila T; Rimm D L
The cell adhesion molecule, E-cadherin, distinguishes mesothelial cells from carcinoma cells in fluids.
Cancer 1997;81(5):293-8.
-
1997: Koslov E R; Maupin P; Pradhan D; Morrow J S; Rimm D L
Alpha-catenin can form asymmetric homodimeric complexes and/or heterodimeric complexes with beta-catenin.
The Journal of biological chemistry 1997;272(43):27301-6.
-
1997: Ghoussoub R A; Rimm D L
Degree of dysplasia following diagnosis of atypical squamous cells of undetermined significance is influenced by patient history and type of follow-up.
Diagnostic cytopathology 1997;17(1):14-9.
-
1997: Rimm D L; Stastny J F; Rimm E B; Ayer S; Frable W J
Comparison of the costs of fine-needle aspiration and open surgical biopsy as methods for obtaining a pathologic diagnosis.
Cancer 1997;81(1):51-6.
-
1995: Pierceall W E; Woodard A S; Morrow J S; Rimm D; Fearon E R
Frequent alterations in E-cadherin and alpha- and beta-catenin expression in human breast cancer cell lines.
Oncogene 1995;11(7):1319-26.
-
1995: Rimm D L; Koslov E R; Kebriaei P; Cianci C D; Morrow J S
Alpha 1(E)-catenin is an actin-binding and -bundling protein mediating the attachment of F-actin to the membrane adhesion complex.
Proceedings of the National Academy of Sciences of the United States of America 1995;92(19):8813-7.
-
1995: Rimm D L; Sinard J H; Morrow J S
Reduced alpha-catenin and E-cadherin expression in breast cancer.
Laboratory investigation; a journal of technical methods and pathology 1995;72(5):506-12.
-
1995: Rimm D L; Holland T E; Morrow J S; Anderson J M
Autoantibodies specific for villin found in patients with colon cancer and other colitides.
Digestive diseases and sciences 1995;40(2):389-95.
-
1994: Rimm D L; Kebriaei P; Morrow J S
Molecular cloning reveals alternative splice forms of human alpha(E)-catenin.
Biochemical and biophysical research communications 1994;203(3):1691-9.
-
1994: Rimm D L; Morrow J S
Molecular cloning of human E-cadherin suggests a novel subdivision of the cadherin superfamily.
Biochemical and biophysical research communications 1994;200(3):1754-61.
-
1991: Thadani V M; Rimm D L; Urquhart L; Fisher L; Williamson P D; Enriquez R; Kim J H; Levy L L
'Locked-in syndrome' for 27 years following a viral illness: clinical and pathologic findings.
Neurology 1991;41(4):498-500.
-
1991: Pollard T D; Rimm D L
Analysis of cDNA clones for Acanthamoeba profilin-I and profilin-II shows end to end homology with vertebrate profilins and a small family of profilin genes.
Cell motility and the cytoskeleton 1991;20(2):169-77.
-
1990: Sinard J H; Rimm D L; Pollard T D
Identification of functional regions on the tail of Acanthamoeba myosin-II using recombinant fusion proteins. II. Assembly properties of tails with NH2- and COOH-terminal deletions.
The Journal of cell biology 1990;111(6 Pt 1):2417-26.
-
1990: Rimm D L; Kaiser D A; Bhandari D; Maupin P; Kiehart D P; Pollard T D
Identification of functional regions on the tail of Acanthamoeba myosin-II using recombinant fusion proteins. I. High resolution epitope mapping and characterization of monoclonal antibody binding sites.
The Journal of cell biology 1990;111(6 Pt 1):2405-16.
-
1989: Rimm D L; Pollard T D
Purification and characterization of an Acanthamoeba nuclear actin-binding protein.
The Journal of cell biology 1989;109(2):585-91.
-
1989: Rimm D L; Sinard J H; Pollard T D
Location of the head-tail junction of myosin.
The Journal of cell biology 1989;108(5):1783-9.
-
1989: Rimm D L; Pollard T D
New plasmid vectors for high level synthesis of eukaryotic fusion proteins in Escherichia coli.
Gene 1989;75(2):323-7.
-
1988: Rimm D L; Pollard T D; Hieter P
Resolution of Acanthamoeba castellanii chromosomes by pulsed field gel electrophoresis and construction of the initial linkage map.
Chromosoma 1988;97(3):219-23.
Sign-in to see more